期刊文献+

稳定性冠心病合并2型糖尿病患者PCI术后的HbA1c水平对预后的影响 被引量:7

Effect of Hb A1c level on prognosis in patients with stable coronary heart disease complicated with type 2 diabetes after percutaneous coronary intervention
下载PDF
导出
摘要 目的探讨稳定性冠心病合并2型糖尿病患者经皮冠状动脉介入术(PCI)治疗后糖化血红蛋白(HbA1c)控制水平对预后的影响。方法选择2017年1月至2019年1月在安康市中心医院心内科接受治疗的冠心病合并2型糖尿病患者130例作为研究对象,所有患者经PCI术后行血糖控制并随访6个月,随访6个月后根据两组患者的HbA1c水平分为对照组和观察组。观察组60例,HbA1c水平均低于7.0%,对照组70例,HbA1c水平均在7.0%以上。术后6个月检测并比较两组患者的血糖相关实验室指标水平变化[包括血清总胆固醇(TC)、甘油三脂(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、空腹血糖(FBG)、餐后2 h血糖(2 hPBG)];比较两组患者随访6个月内的不良心血管事件(MACE)发生情况,并采用多因素Logistic回归分析血糖控制水平与MACE的相关性。结果PCI术后随访6个月,观察组患者的HbA1c水平为(6.41±0.23)%,明显低于对照组的(8.95±1.20)%,差异有统计学意义(P<0.05);观察组和对照组患者的TC[(5.25±0.05)mmol/L vs(6.26±1.15)mmol/L]、TG[(2.40±0.18)mmol/L vs(3.43±1.17)mmol/L]、LDL-C[(3.33±0.01)mmol/L vs(4.37±0.51)mmol/L]、FBG[(7.09±1.21)mmol/L vs(9.52±2.29)mmol/L]、餐后2 hPBG[(8.03±1.19)mmol/L vs(10.02±2.25)mmol/L]比较,观察组明显低于对照组,而观察组患者的HDL-C为(1.51±0.14)mmol/L,明显高于对照组的(0.75±0.16)mmol/L,差异均有统计学意义(P<0.05);随访期间观察组患者的MACE发生率为5.0%,明显低于对照组的20.0%,差异具有统计学意义(P<0.05);经多因素Logistic回归分析结果显示,只有血糖控制水平是否良好是MACE事件发生的危险因素(P<0.05)。结论稳定性冠心病合并2型糖尿病患者PCI术后有效控制HbA1c水平有助于减少不良血管事件的发生,改善临床预后。 Objective To investigate the effect of glycosylated hemoglobin(HbA1 c)control on prognosis in patients with stable coronary heart disease complicated with type 2 diabetes after percutaneous coronary intervention(PCI).Methods A total of 130 patients with coronary heart disease and type 2 diabetes who were treated in the Department of Cardiology,Ankang Central Hospital from January 2017 to January 2019 were enrolled.All patients underwent blood glucose control after PCI and were followed up for 6 months.After 6 months of follow-up,the Hb A1 c levels of the two groups were divided into control group and observation group.Patients in the observation group(n=60)had Hb A1 c level lower than 7.0%,while patients in the control group(n=70)had Hb A1 c level above 7.0%.Six-month postoperative follow-up was performed to detect and compare changes in blood glucose related laboratory indicators,including serum total cholesterol(TC),triglyceride(TG),low-density lipoprotein cholesterol(LDL-C),high-density lipoprotein cholesterol(HDL-C),fasting blood glucose(FBG),and 2 h postprandial blood glucose(2 h PBG)in the two groups.The incidence of adverse cardiovascular events(MACE)within 6 months was compared between the two groups,and the correlation between blood glucose control level and MACE was analyzed by multivariate Logistic regression.Results After PCI,the Hb A1 c level in the observation group was(6.41±0.23)%,significantly lower than(8.95±1.20)%in the control group(P<0.05).TC,TG,LDL-C,FBG,2 h PBG in the observation group were significantly lower than those in the control group(P<0.05):(5.25±0.05)mmol/L vs(6.26±1.15)mmol/L,(2.40±0.18)mmol/L vs(3.43±1.17)mmol/L,(3.33±0.01)mmol/L vs(4.37±0.51)mmol/L,(7.09±1.21)mmol/L vs(9.52±2.29)mmol/L,and(8.03±1.19)mmol/L vs(10.02±2.25)mmol/L.HDL-C in the observation group was(1.51±0.14)mmol/L,which was significantly higher than(0.75±0.16)mmol/L in the control group(P<0.05).During the follow-up,the incidence of MACE in the observation group was 5.0%,which was significantly lower than 20.0%in the control group,and the difference was statistically significant(P<0.05).Multivariate Logistic regression analysis showed that blood glucose control level was the risk factor for MACE events(P<0.05).Conclusion The effective control of HbA1 c after PCI in patients with stable coronary heart disease combined with type2 diabetes can reduce the incidence of adverse vascular events and improve the clinical prognosis.
作者 刘莎 陈庭燕 李毅 孙朝阳 周坤 刘发俊 LIU Sha;CHEN Ting-yan;LI Yi;SUN Chao-yang;ZHOU Kun;LIU Fa-jun(Department of Cardiology,Ankang Central Hospital,Ankang 725000,Shaanxi,CHINA)
出处 《海南医学》 CAS 2020年第5期559-562,共4页 Hainan Medical Journal
关键词 经皮冠状动脉介入 冠心病 糖尿病 糖化血红蛋白 预后 Percutaneous coronary intervention Coronary heart disease(CHD) Diabetes HbA1c Prognosis
  • 相关文献

参考文献15

二级参考文献75

  • 1詹晓蓉,母义明,潘长玉,陆祖谦,金文胜,陆菊明,杨波.糖调节异常患者血中游离脂肪酸水平与动脉粥样硬化的关系[J].中国糖尿病杂志,2006,14(5):369-371. 被引量:17
  • 2李莉,郭明秋,苏天璐,王玉洁,谭海艳,殷晓婕.血清超敏C反应蛋白测定在冠心病中的临床应用[J].中国实验诊断学,2007,11(2):190-191. 被引量:15
  • 3许宜冠,周胜华,李玉光,沈向前,胡信群,方臻飞,陈畅,许端敏.冠心病患者冠状动脉病变与心率变异性的关系[J].心脏杂志,2007,19(5):578-581. 被引量:12
  • 4中华医学会糖尿病学分会.中国2型糖尿病防治指南[Z].2010.
  • 5Robert K, Susanne Z, Teake K. Cytokines and atherosclerosis: a comprehensive review of studies in mice [J]. Cardiovasc Res, 2008, 79(3): 360-376.
  • 6Pasqui AL, Bova G, Maffei S, et al. Immune factors in atherosclero- sis [J]. Ann Ital Med Int, 2005, 20(2): 81-89.
  • 7Matsubara M, Maruokas S, Katayose S. Inverse relationship between plasma adiponectin and leptin concenlrations in normal-weight and obese women [J]. Eur J Endocrinol, 2002, 147(2): 173-180.
  • 8Beltowski J. Adiponectin and resisting-new hormones of white adi- pose tissue [J]. Med Sci Moint, 2003, 9(2): 55-61.
  • 9Su H, Lan WB, Ma XL in diabetes mellitus type 2: molecular mechanisms and clinical significance [J]. Clin Exp Pharmacol Physiol, 2011, 38(12): 897-904.
  • 10Ezenwaka CE, KaUoo R. Caribbean female patients with type 2 dia- betes mellitus have lower serum levels of adiponectin than nondia- betic subjects [J]. Neth J Med, 2005, 63(2): 64-69.

共引文献240

同被引文献88

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部